Molecular pathogenesis of pulmonary arterial hypertension - Test2 - elhamkhani - TriplyDB

Molecular pathogenesis of pulmonary arterial hypertension

Molecular pathogenesis of pulmonary arterial hypertension

http://www.wikidata.org/entity/Q24634317

about

Pulmonary Hypertension and Indicators of Right Ventricular Function Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series)MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists Pulmonary vascular mechanics: important contributors to the increased right ventricular afterload of pulmonary hypertension A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury DNA Damage and Pulmonary Hypertension Targeting the Wnt signaling pathways in pulmonary arterial hypertension Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat Model Recent advances in the management of pulmonary arterial hypertension From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling Role of oxidized lipids in pulmonary arterial hypertension Treatment-related biomarkers in pulmonary hypertension Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells "Nocturnal seizures" in idiopathic pulmonary arterial hypertension.New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Emerging role of exosome-mediated intercellular communication in vascular remodeling Estrogen receptor-dependent attenuation of hypoxia-induced changes in the lung genome of pulmonary hypertension rats.Addressing the challenges of phenotyping pediatric pulmonary vascular disease Role of epigenetics in pulmonary hypertension Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Genetics of pulmonary hypertension Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt.HypoxamiR regulation and function in ischemic cardiovascular diseases.Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats Sex-dependent influence of endogenous estrogen in pulmonary hypertension.Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.

P2860

Q26744781-BD6A9172-03D0-4CE1-86BE-7F887C909E6F Q26772286-84782DC1-9545-416B-801B-F09933D84B9E Q26796557-60C4B95D-738D-4B80-9554-E20CE3DFA06E Q26860314-30D1A51F-8DA4-48DF-9DF0-AE629D10CCD8 Q26862662-A6EDED43-AAF9-46D4-BA10-A72536B65B95 Q26992169-0C3B8CAB-770E-4416-9564-D90590C6010A Q27005594-D4534EAE-A798-4985-9381-6B4779FA9DF2 Q27006826-FDBA4A40-E27F-46C1-8CFA-16ACAE7CEEE4 Q27009717-06E53B06-ABA0-471C-86BF-37E4219FC6F4 Q27026465-AB3927D7-6BB5-4B1C-B377-E1E355F9E069 Q27313498-C7926D83-7464-4E5A-AB82-938AB4C000AD Q27702090-C807F926-36C4-4779-9E06-55095E07A9DF Q28075707-58617BF0-CF4C-4BCC-B7C7-46E89367F201 Q28076273-E4264BF9-3E8F-456B-83B6-6C52AB87EE53 Q28078566-2303159D-690F-4A61-9ABB-F78B48CE0CE7 Q28081276-CB2F01AE-F772-4931-A12B-0B526BC8A124 Q28581058-7437E138-CEBA-46FF-B777-F4C1F5D5AD7C Q33163402-0F2E7B60-2665-49A2-A5C9-221FA7496CC3 Q33432069-01E81444-F0DE-4E91-84C8-BCBC46FED24F Q33649005-67CFE5AD-8DE8-4AFD-8F8F-BD15AE1AE5F4 Q33738546-D96F6FBA-D78C-4C83-97D6-A738E4AD16B9 Q33738631-37DFFB59-2BFF-4243-83C6-4CAD07CD72C9 Q33764713-A654C6F2-96CF-491A-A317-623C1EE76D97 Q33799629-0DEC7277-6FCD-4FA9-9C19-A5A7FF5B878A Q33806253-A836EC0A-CA8C-453F-973F-0F6CBB17B88E Q33965854-0FEA90FA-393D-4683-B63B-299715521B54 Q34061821-08A0E0B8-E154-4384-BB08-74969CBB8F90 Q34082010-7AFE3DEB-712D-45A4-96E9-0E55D8582369 Q34305561-F5D30900-3BB5-424A-A5DC-FFD45FCCD1A8 Q34356181-FBD90C11-1127-4D26-A931-03082FC77B4E Q34425976-D43D17DE-1864-48C6-9173-22158CEFEB8F Q34782588-A207C286-DE87-4860-8D8C-990ED845B48C Q34924892-EAD24AC3-79D2-473F-806F-E7D2F3591E1D Q34945488-18FF68C0-3F06-4CB4-BAEE-AAFD0991467A Q35002833-960A0F99-10CB-40D7-B746-9E6B9D622E81 Q35086382-A92F290A-3D87-4224-B783-92301EA50C4D Q35108148-13744F36-7B44-4659-BDA8-D5CA93ED9748 Q35115837-539C27ED-0882-4E53-8E51-8337F8A50691 Q35153971-21D8B631-D0F8-4F3F-83F8-5E6DFDB13F86 Q35183959-BDA247E5-A97B-475B-BE4A-246DFD438C88

P2860

Molecular pathogenesis of pulmonary arterial hypertension

http://www.wikidata.org/entity/Q24634317

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Molecular pathogenesis of pulmonary arterial hypertension

@ast

Molecular pathogenesis of pulmonary arterial hypertension

@en

Molecular pathogenesis of pulmonary arterial hypertension

@nl

type

label

Molecular pathogenesis of pulmonary arterial hypertension

@ast

Molecular pathogenesis of pulmonary arterial hypertension

@en

Molecular pathogenesis of pulmonary arterial hypertension

@nl

prefLabel

Molecular pathogenesis of pulmonary arterial hypertension

@ast

Molecular pathogenesis of pulmonary arterial hypertension

@en

Molecular pathogenesis of pulmonary arterial hypertension

@nl

P1433

Q24634317-14CF323B-FA03-4DAE-A2D9-D621B6F5445B

P1476

Q24634317-C9E9C73C-2197-4895-BF5D-5C661E9A3CE3

P2093

Q24634317-69CD0150-FAF6-40EA-A18E-A8ED35A990C5

P2860

Q24634317-01455869-3C26-4F23-9821-B04202228EF3

Q24634317-03797B13-7275-4F62-8812-F366E575D1CC

Q24634317-0430FFD6-BA89-41AD-9B06-7D9AED78E0C9

Q24634317-10B60922-0A3B-4B5B-B4DD-89432DADA235

Q24634317-11A762D8-631B-48E2-B0CF-637361AB277F

Q24634317-16E5F267-139A-4E05-ABD4-FA290F3335F0

Q24634317-17468E5B-98D5-400D-8E8C-C5082AC230A1

Q24634317-18723F7A-8F62-4BB2-AA9F-852997DCB49F

Q24634317-1AA7614A-6D61-49E1-9A1A-11D648EEB921

Q24634317-1B7C35D8-C092-4500-9ECF-B5E3512CB1BF

P304

Q24634317-D79B62C3-6311-4393-AB5D-EC846A824B63

P31

Q24634317-5D023AFA-E189-4775-BD7C-DDA0BAA44852

Q24634317-77bec63b-bd99-464e-bd0d-de560523820f

P3181

Q24634317-0D8DEE73-F1C1-445D-B13A-FA69C9EA019D

P356

Q24634317-ADF7CFE0-8A47-4B63-996C-1FF8D980DF7C

P407

Q24634317-1D956216-F678-4F54-B611-CAEE6494F70E

P433

Q24634317-ECF29BBB-9AF8-467C-A3D8-433F679C58FB

P478

Q24634317-57759067-2F23-4F3C-AA6F-3A3147701C01

P577

Q24634317-D8CD8E32-50FF-4D96-9F01-9C5DCB07E7D2

P698

Q24634317-6E83B96C-1929-4F99-A7FF-92D4BDA7C774

P921

Q24634317-23E93CF1-294F-410C-BCFB-6C96CC1F1A07

Q24634317-71E82A7A-7EA4-4DA9-B4A3-6342F7C1BBF2

P932

Q24634317-52276425-3A5B-43A9-ADE1-71002D813DEB

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Molecular pathogenesis of pulmonary arterial hypertension

@en

P2093

Marlene Rabinovitch

http://www.w3.org/2001/XMLSchema#string

P2860

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension

Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth

Disruption of methylarginine metabolism impairs vascular homeostasis

Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension

P304

4306-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

580218

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI60658

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23202738

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3533531

http://www.w3.org/2001/XMLSchema#string